Patents
Patents for C07D 243 - Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms (5,961)
06/2007
06/27/2007CN1988907A Dual small molecule inhibitors of cancer and angiogenesis
06/26/2007US7235656 Anxiolytic agents with reduced sedative and ataxic effects
06/21/2007WO2007036532A3 Selected cgrp antagonists, methods for the production thereof and their use as medicaments
06/21/2007US20070142393 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
06/20/2007EP1798231A2 Intermediate products for the preparation of antibacterial compounds
06/20/2007EP1798227A1 Serotonin 5-ht3 receptor agonist
06/19/2007US7232816 Phosphodiesterase inhibitors; used to treat inflammatory conditions, allergies such as rhinitis, respiratory system disorders and cancer
06/14/2007WO2007040840A3 Aminodiazepines as toll-like receptor modulators
06/14/2007US20070135421 e.g. Methyl 3-[(4S)-8-bromo-1-methyl-6-(2-pyridinyl)-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl]propanoate; GABAA (gamma aminobutiric acid) receptor antagonist; sedative-hypnotic, anxiolytic, muscle relaxant and anticonvulsant; anesthesia
06/14/2007US20070135420 Short-acting benzodiazepines
06/14/2007US20070135419 Short-acting benzodiazepines
06/14/2007US20070135418 Compositions and methods relating to novel compounds and targets thereof
06/14/2007US20070135414 Tachykinin Antagonists
06/14/2007US20070134161 Methods of determining beta-iii tubulin expression
06/12/2007US7229984 Dibenzoxazepinone derivatives and uses thereof
06/07/2007WO2007036533A3 Selected cgrp antagonists, a method for the production thereof and use in the form of drugs
06/06/2007CN1319958C Phenyl-piperazine derivatives as serotonin reuptake inhibitors
06/05/2007USRE39680 Sleep disorders associated with 5-HT2A serotonin receptor modulation; antagonists or agonists
05/2007
05/31/2007US20070123519 Benzo-1,4-diazepin-2-one derivatives as phosphodiesterase pde2 inhibitors, preparation and therapeutic use thereof
05/30/2007EP0914605B1 Molecular model for vla-4 inhibitors
05/30/2007CN1318421C Non-nucleoside reverse transcriptase inhibitors
05/30/2007CN1318420C Dipyridodiazepinones as reverse transcriptase inhibitors
05/29/2007US7223753 Diazabicyclic biaryl derivatives
05/29/2007US7223752 Biphenyl vasopressin agonists
05/29/2007US7223751 Sulfonamide derivatives, intermediate thereof, its preparation methods, and pharmaceutical composition comprising the same
05/23/2007EP1417183B1 Multidentate aza ligands able to complex metal ions and the use thereof in diagnostics and therapy
05/23/2007EP1254895B1 Nitrogenous cyclic compounds and pharmaceutical compositions containing the same
05/23/2007CN1317280C Novel diazabicyclic aryl derivatives
05/22/2007US7220741 As cholinergic ligands at the nicotinic acetylcholine receptors and modulators of the monoamine receptors and transporters, for therapy of central nervous system (CNS), the peripheral nervous system (PNS), diseases or disorders related to smooth muscle contraction, endocrine diseases or disorders
05/22/2007US7220739 Therapeutic application of pro-apoptotic benzodiazepines
05/16/2007EP1785425A2 Novel 1,4-diazabicycloalkane derivatives, their preparation and use
05/16/2007EP1784408A1 Triazolobenzodiazepines and their use as vasopressin antagonists
05/16/2007EP1784390A2 Substituted benzofused heterocycles
05/10/2007WO2007053618A1 Prodrugs of muscarinic agonists and methods of treatment of neuropsychiatric disorders
05/10/2007WO2007053193A2 Unsolvated benzodiazepine compositions and methods
05/10/2007WO2007053145A1 Haloperidol analogs
05/10/2007US20070106074 Iron catalyzed cross-coupling reactions of imidoyl derivatives
05/10/2007CA2626586A1 Stable composition for a pharmaceutical formulation containing olanzapine
05/10/2007CA2611031A1 Unsolvated benzodiazepine compositions and methods
05/09/2007EP0711177B1 Improvements relating to the preparation of prodrugs
05/08/2007US7214673 For therapy of psychosis and bipolar disorder
05/03/2007CA2624353A1 Tyrosine kinase inhibitors
05/02/2007EP1778658A2 Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof
05/02/2007EP1778649A1 A PROCESS FOR PRODUCING PURE FORM OF 2-METHYL-4-(4-METHYL-1-PIPERAZINYL)-10H-THIENO[2,3-b][1,5]BENZODIAZEPINE
05/02/2007CN1956971A Novel fused heterocycles and application thereof
05/02/2007CN1955180A 1,2,3,4,7,8-hexahydro-6H-[1,4]diazepino[6,7,1-IJ] quinoline derivatives as antipsychotic and antiobesity agents
05/02/2007CN1955164A Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
05/02/2007CN1313472C Cellular accumulation of phosphonate analogs of HIV protease inhibitor compounds and the compounds as such
04/2007
04/26/2007US20070093529 Diacylhydrazine derivatives
04/26/2007US20070093485 Substituted n-phenyl sulfonamide bradykinin antagonists
04/26/2007US20070093475 Short-acting benzodiazepines
04/26/2007US20070092656 Reactive cyclic carbonates and ureas used for modifying biomolecules, polymers, and surfaces
04/25/2007EP1776160A1 Novel serotonin receptor ligands and their uses thereof
04/24/2007US7208497 Substituted piperazines and diazepanes
04/24/2007US7208140 Trimeric macrocyclic substituted benzene derivatives
04/18/2007EP1773789A1 Process for the preparation of 3-(4-piperidinyl)- 2,3,4,5-tetrahydro-1,3-benzodiazepin-2(1h)-on
04/18/2007EP1773779A1 Nicotinic receptor agonists for the treatment of inflammatory diseases
04/18/2007CN1950374A Tetraazabenzo[e]azulene derivatives and analogs thereof
04/18/2007CN1950346A N-desmethylclozapine crystalline forms
04/17/2007US7205304 medicine to inhibit proliferative conditions, such as cancer and psoriasis
04/17/2007US7205294 Selected CGRP-antagonists process for preparing them and their use as pharmaceutical compositions
04/12/2007WO2006104889A3 Novel compounds
04/12/2007WO2006078598A3 Mitotic kinesin inhibitors
04/12/2007US20070082897 Acylated indanyl amines and their use as pharmaceuticals
04/12/2007US20070082888 Containing a piperidine ring, e.g., N-(p-(1-(alpha(propyl-aminocarbonyl)benzyl)piperidin-4-yl)phen yl)-o-(p-CF3-phenyl)- benzamide, for therapy of hyperlipidemia, obesity and type II diabetes
04/11/2007EP1399444B1 Novel heterocyclic compounds, method for preparing same and use thereof as medicines, in particular as anti-bacterial agents
04/11/2007CN1946396A Medicine for prevention and/or treatment of ischemic circulatory disease
04/05/2007WO2007038512A2 Phosphate prodrugs of a farnesyl dibenzodiazepinone, processes for their production and their use as pharmaceuticals
04/05/2007WO2007036533A2 Selected cgrp antagonists, a method for the production thereof and use in the form of drugs
04/05/2007WO2007036532A2 Selected cgrp antagonists, methods for the production thereof and their use as medicaments
04/05/2007US20070078112 Phosphate prodrugs of a farnesyl dibenzodiazepinone, processes for their production and their use as pharmaceuticals
04/05/2007CA2623156A1 Selected cgrp antagonists, methods for the production thereof and their use as medicaments
04/04/2007EP1770087A1 Selected CGRP antagonists, process for their preparation as well as their use as medicaments
04/04/2007EP1770086A1 Selected CGRP antagonists, process for their preparation as well as their use as medicaments
04/04/2007CN1308313C Fused azepine drivatives and their use as antidiuretic agents
03/2007
03/29/2007WO2007034127A1 Benzodiazepine derivatives for treating hepatitis c infection
03/29/2007CA2622592A1 Benzodiazepine derivatives for treating hepatitis c infection
03/28/2007CN1938280A Thiourea compositions and uses thereof
03/28/2007CN1307156C Polyarylcarboxamides useful as lipid lowering agents
03/27/2007US7196108 Bicyclic heterocycles for the treatment of diabetes and other diseases
03/27/2007US7196078 Trisubstituted and tetrasubstituted pyrazolopyrimidines as cyclin dependent kinase inhibitors
03/27/2007US7196077 Tachykinin antagonists
03/22/2007US20070066676 2-(2,3,3a,8b-Tetrahydro-1H-cyclopenta[b]indol-4-yl-substituted acetamides, acetonitriles and ethylamines as intermediates
03/22/2007US20070066600 Compounds
03/22/2007US20070066599 New compounds
03/22/2007US20070066598 Compounds
03/20/2007US7192954 Calcitonin Gene-Related Peptide (CGRP) antagonists for migraine and cluster headaches; 5'-acylamino-spiro[imidazolidine-4,2'-indane]-2,5-dione derivatives
03/20/2007US7192950 Psychological disorders; eating disorders; dietetics
03/15/2007US20070060624 Novel bioisosteres of actinonin
03/15/2007US20070060574 Phenyl-piperazine derivatives as serotonin reuptake inhibitors
03/14/2007EP1761508A1 Stereospecific anxiolytic and anticonvulsant agents with reduced muscle-relaxant, sedative-hypnotic and ataxic effects
03/14/2007EP1761507A1 Phosphodiesterase-inhibiting compounds of the 2,3-benzodiazepine type
03/14/2007CN1929848A Benzodiazepines for treating or preventing or preventing RSV infection
03/13/2007US7189711 Muscle relaxants; central nervous system disorders; Parkinson's disease; Alzheimer's disease; strokes
03/13/2007CA2267224C Vitronectin receptor antagonists
03/08/2007US20070054881 Anxiolytic agents with reduced sedative and ataxic effects
03/08/2007CA2616797A1 Benzodiazepine derivatives , their preparation and the therapeutic use thereof
03/07/2007EP1758884A2 N-cyclic sulfonamido inhibitors of gamma secretase
03/07/2007EP1381370B1 N-biphenylcarbonyl- and n-phenylpyridylcarbonyl substituted bi- and tricyclic azepines and diazepines as vasopressing agonists
03/06/2007US7186828 Cyclic urea compounds and preparation thereof
1 ... 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 ... 60